Anti Smooth Muscle Antibody

Categories ,

Anti-Smooth Muscle Antibody (ASMA) Test: Overview

The Anti-Smooth Muscle Antibody (ASMA) test detects autoantibodies that target smooth muscle proteins, particularly actin, and is primarily used to help diagnose autoimmune hepatitis (AIH), Type 1. ASMA may also be present in other liver diseases and autoimmune conditions.


Purpose of the Test

Diagnose Autoimmune Hepatitis (AIH), especially Type 1
Differentiate AIH from other liver diseases (e.g., viral hepatitis, cirrhosis, fatty liver disease)
Monitor disease activity in autoimmune liver disorders
Investigate unexplained liver dysfunction and chronic liver inflammation


Interpreting Results

Result Interpretation
Negative No detectable ASMA (does not completely rule out AIH)
Low Positive (1:20 – 1:40 titer) May indicate mild autoimmune activity or other liver disease
High Positive (>1:80 titer) Strongly suggests autoimmune hepatitis (Type 1 AIH)

🔹 ASMA positivity is found in 70-80% of Autoimmune Hepatitis (Type 1) cases.
🔹 Higher titers (>1:80) are more strongly associated with AIH.
🔹 Low ASMA titers may be seen in viral hepatitis (Hep B/C), cirrhosis, or primary biliary cholangitis (PBC).


Clinical Significance

  • Autoimmune Hepatitis (Type 1 AIH) → Chronic immune-mediated liver inflammation.

  • Cirrhosis & Chronic Liver Disease → ASMA may be present but at lower titers.

  • Viral Hepatitis (Hepatitis B, C, D) → Occasionally positive at low levels.

  • Primary Biliary Cholangitis (PBC) → More commonly associated with anti-mitochondrial antibodies (AMA) but may have ASMA positivity.

  • Other Autoimmune Conditions (e.g., SLE, rheumatoid arthritis, scleroderma) → Rarely associated with ASMA.


Additional Tests for Autoimmune Liver Disease

Liver Function Tests (ALT, AST, ALP, Bilirubin, Albumin, PT/INR) → Evaluate liver inflammation and damage.
Anti-Liver/Kidney Microsomal (LKM) Antibodies → Distinguishes AIH Type 2.
Anti-Mitochondrial Antibodies (AMA) → Diagnoses Primary Biliary Cholangitis (PBC).
IgG Levels → Often elevated in autoimmune hepatitis.
Liver Biopsy → Confirms AIH and assesses liver fibrosis/cirrhosis.


Next Steps if ASMA is Positive

🔹 Assess liver function (ALT, AST, bilirubin, albumin) to evaluate disease severity.
🔹 Consult a hepatologist for further evaluation if AIH is suspected.
🔹 Liver biopsy may be recommended to confirm AIH and guide treatment.
🔹 Treatment for AIH often includes steroids (prednisone) and immunosuppressants (azathioprine, mycophenolate mofetil).
🔹 Regular monitoring for disease progression and potential liver damage.

Original price was: ₹2,799.00.Current price is: ₹1,399.00.